Health Technology Assessment (HTA)
Comprehensive Health Technology Assessment (HTA) Services
- Home
- Services
- Health Technology Assessment (HTA)
Understanding HTA and Its Importance
Health Technology Assessment (HTA) is a systematic evaluation process that examines the clinical, economic, and social implications of health interventions. By synthesising scientific evidence, HTAs help stakeholders—including government bodies, healthcare providers, and pharmaceutical companies—make informed decisions about adopting new technologies.
Key Benefits
- Clinical Effectiveness: Ensures that health technologies provide proven therapeutic benefits.
- Economic Evaluation: Assesses the cost-effectiveness of interventions, balancing efficacy with financial impact.
- Policy Support: Guides strategic policy and funding decisions to optimise healthcare delivery.
Contact Us
At Clevidence, we specialise in providing thorough health technology assessments (HTAs) that support decision-makers with robust, evidence-based evaluations. Our HTAs are essential for assessing the clinical effectiveness, safety, and cost-effectiveness of new and existing health technologies, ensuring optimal outcomes for patients and stakeholders.
Rigorous Methodologies for Reliable Outcomes
Clevidence employs a comprehensive, multi-step approach to HTA, ensuring that each assessment meets the highest standards of methodological rigour. Our process includes evidence synthesis, clinical evaluations, and economic modelling.
Methodological Steps
- Systematic Literature Review: We conduct extensive reviews of existing studies to compile data on the clinical efficacy and safety of health interventions.
- Economic Modelling: Using cost-effectiveness, cost-utility, and budget impact models, we evaluate the economic value of adopting specific health technologies.
- Stakeholder Engagement: Incorporating feedback from key stakeholders to align the HTA with practical, real-world needs.
Our Core Competencies in HTA
Clinical Efficacy and Safety
- Assessing how health technologies perform in controlled and real-world settings, focusing on patient outcomes and safety profiles.
Cost-Effectiveness Analysis (CEA)
- Calculating cost per quality-adjusted life year (QALY) to determine value for money.
Budget Impact Analysis (BIA)
- Forecasting the financial implications of adopting new interventions over short- and long-term periods.
Network Meta-Analysis (NMA)
- Providing comparative analysis of multiple treatments when direct head-to-head trials are unavailable.
The Clevidence Advantage
Clevidence’s HTA services are characterised by transparency, rigour, and adaptability. Our commitment to high standards ensures that stakeholders receive assessments that are both scientifically robust and practically relevant.
Key Differentiators
- Experienced Professionals: Led by experts with extensive backgrounds in health economics and clinical analysis.
- Customised Solutions: Each HTA is tailored to fit the specific needs and goals of our clients.
- Transparent Reporting: Our reports provide clear, actionable insights, ensuring that decision-makers can trust the data presented.
FAQ
Frequently Asked Questions
Health Technology Assessment (HTA) is a systematic evaluation process that analyses the clinical, economic, and social implications of health interventions. It plays a critical role in healthcare decision-making, guiding stakeholders—including government bodies, healthcare providers, and pharmaceutical companies—on whether to adopt new technologies. By assessing factors such as clinical effectiveness, safety, and cost-effectiveness, HTAs help ensure that patients receive the best possible care while optimising resource allocation.
At Clevidence, our HTA process follows a rigorous, multi-step methodology designed to deliver reliable, evidence-based results. We begin with a comprehensive systematic literature review to gather data on the clinical efficacy and safety of the intervention. This is followed by economic modelling, where we evaluate the cost-effectiveness using techniques like cost-utility analysis and budget impact analysis. Finally, we engage key stakeholders to ensure our findings are aligned with practical, real-world needs. This structured approach guarantees high-quality, actionable insights for our clients.
Real-World Applications of Our HTA Expertise
Optimising Market Entry for an Innovative Treatment.
Clevidence conducted a comprehensive HTA that supported a major pharmaceutical company in securing reimbursement approval, leading to expedited market access.
The client achieved faster integration into healthcare systems, benefiting both patients and stakeholders.
